Literature DB >> 33484763

Dupilumab therapy for alopecia areata in pediatric patients with concomitant atopic dermatitis.

Paige L McKenzie1, Leslie Castelo-Soccio2.   

Abstract

Entities:  

Year:  2021        PMID： 33484763     DOI： 10.1016/j.jaad.2021.01.046

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  7 in total

Review 1.  [Modern systemic therapies for atopic dermatitis : Which factors determine the choice of therapy?]

Authors:  Stephan Traidl; Annice Heratizadeh
Journal:  Dermatologie (Heidelb)       Date:  2022-06-01

Review 2.  Biologic Therapies for the Management of Cutaneous Findings in Genodermatoses: A Review.

Authors:  Tejas P Joshi; Hannah Y Wang; Prazwal Athukuri; Sarah Bohac; Morgan A Farr; Darien Hinson; Justin A Kahla; Nasim Khalfe; Dylan B McBee; Rachel Stroh; Nicole Walters; Vicky Ren
Journal:  Am J Clin Dermatol       Date:  2022-05-23       Impact factor: 6.233

3.  Dupilumab, incontinentia pigmenti, and alopecia: A serendipitous observation.

Authors:  Ashley Torkan Zilberstein; Erica L Teng; Anthony J Mancini
Journal:  JAAD Case Rep       Date:  2022-09-21

Review 4.  An Overview of Off-Label Use of Humanized Monoclonal Antibodies in Paediatrics.

Authors:  Roberto Bernardini; Gaia Toschi Vespasiani; Arianna Giannetti
Journal:  Medicina (Kaunas)       Date:  2022-04-29       Impact factor: 2.948

5.  Dupilumab for the treatment of alopecia areata in children with atopic dermatitis.

Authors:  Sung Kyung Cho; Brittany G Craiglow
Journal:  JAAD Case Rep       Date:  2021-07-27

6.  Long-Term Efficacy of Dupilumab in Alopecia Areata.

Authors:  Maansi Kulkarni; Craig A Rohan; Jeffrey B Travers; Rocco Serrao
Journal:  Am J Case Rep       Date:  2022-06-21

7.  Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata.

Authors:  Reiko Kageyama; Taisuke Ito; Shiho Hanai; Naomi Morishita; Shinsuke Nakazawa; Toshiharu Fujiyama; Tetsuya Honda; Yoshiki Tokura
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.